000 01241 a2200337 4500
005 20250518002813.0
264 0 _c20181106
008 201811s 0 0 eng d
022 _a1532-8708
024 7 _a10.1053/j.seminoncol.2018.05.002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBergado Báez, Gretchen
245 0 0 _aHER1-based vaccine: Simultaneous activation of humoral and cellular immune response.
_h[electronic resource]
260 _bSeminars in oncology
_c01 2018
300 _a75-83 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aCancer Vaccines
_ximmunology
650 0 4 _aErbB Receptors
_ximmunology
650 0 4 _aHumans
650 0 4 _aImmunity, Cellular
_xdrug effects
650 0 4 _aImmunity, Humoral
_xdrug effects
650 0 4 _aImmunotherapy, Active
_xmethods
650 0 4 _aModels, Immunological
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aTreatment Outcome
700 1 _aHernández Fernández, Diana R
700 1 _aMazorra Herrera, Zaima
700 1 _aSánchez Ramírez, Belinda
773 0 _tSeminars in oncology
_gvol. 45
_gno. 1-2
_gp. 75-83
856 4 0 _uhttps://doi.org/10.1053/j.seminoncol.2018.05.002
_zAvailable from publisher's website
999 _c28936096
_d28936096